778 related articles for article (PubMed ID: 17197923)
21. Prognostic value of the preserved expression of the E-cadherin and catenin families of adhesion molecules and of beta-catenin mutations in synovial sarcoma.
Saito T; Oda Y; Sakamoto A; Tamiya S; Kinukawa N; Hayashi K; Iwamoto Y; Tsuneyoshi M
J Pathol; 2000 Nov; 192(3):342-50. PubMed ID: 11054718
[TBL] [Abstract][Full Text] [Related]
22. Anaplastic sarcoma of the kidney: a clinicopathologic study of 20 cases of a new entity with polyphenotypic features.
Vujanić GM; Kelsey A; Perlman EJ; Sandstedt B; Beckwith JB
Am J Surg Pathol; 2007 Oct; 31(10):1459-68. PubMed ID: 17895746
[TBL] [Abstract][Full Text] [Related]
23. First case report of a fetal synovial sarcoma confirmed by molecular detection of SYT-SSX fusion gene transcripts.
Duband S; Morrison AL; Pasquier D; Coindre JM; Pasquier B; Péoc'h M
Am J Perinatol; 2008 Sep; 25(8):517-20. PubMed ID: 18720326
[TBL] [Abstract][Full Text] [Related]
24. SYT-SSX fusion genes and prognosis in synovial sarcoma.
Mezzelani A; Mariani L; Tamborini E; Agus V; Riva C; Lo Vullo S; Fabbri A; Stumbo M; Azzarelli A; Casali PG; Gronchi A; Sozzi G; Pierotti MA; Pilotti S
Br J Cancer; 2001 Nov; 85(10):1535-9. PubMed ID: 11720441
[TBL] [Abstract][Full Text] [Related]
25. [Expressions and significance of E-cadherin and beta-catenin in synovial sarcoma].
Sun BC; Sun Y; Zhao XL; Liu YX; Zhang SW; Liu YX
Zhonghua Zhong Liu Za Zhi; 2005 Dec; 27(12):727-30. PubMed ID: 16483482
[TBL] [Abstract][Full Text] [Related]
26. Prospective evaluation of TLE1 as a diagnostic immunohistochemical marker in synovial sarcoma.
Jagdis A; Rubin BP; Tubbs RR; Pacheco M; Nielsen TO
Am J Surg Pathol; 2009 Dec; 33(12):1743-51. PubMed ID: 19809272
[TBL] [Abstract][Full Text] [Related]
27. Molecular detection of SS18-SSX fusion gene transcripts by cRNA in situ hybridization in synovial sarcoma using formalin-fixed, paraffin-embedded tumor tissue specimens.
Kanemitsu S; Hisaoka M; Shimajiri S; Matsuyama A; Hashimoto H
Diagn Mol Pathol; 2007 Mar; 16(1):9-17. PubMed ID: 17471153
[TBL] [Abstract][Full Text] [Related]
28. Reverse transcription-polymerase chain reaction in situ hybridization for SYT-SSX fusion gene transcripts in synovial sarcomas.
Kawauchi S; Fukuda T; Chochi Y; Kondo T; Oga A; Sasaki K
Int J Mol Med; 2005 Oct; 16(4):763-6. PubMed ID: 16142418
[TBL] [Abstract][Full Text] [Related]
29. Dysadherin expression in gastrointestinal stromal tumors (GISTs).
Liang JF; Zheng HX; Xiao H; Li N; Cheng CX; Wang HK
Pathol Res Pract; 2009; 205(7):445-50. PubMed ID: 19217217
[TBL] [Abstract][Full Text] [Related]
30. Monophasic fibrous and poorly differentiated synovial sarcoma: immunohistochemical reassessment of 60 t(X;18)(SYT-SSX)-positive cases.
Pelmus M; Guillou L; Hostein I; Sierankowski G; Lussan C; Coindre JM
Am J Surg Pathol; 2002 Nov; 26(11):1434-40. PubMed ID: 12409719
[TBL] [Abstract][Full Text] [Related]
31. Oncoproteins and proliferation markers in synovial sarcomas: a clinicopathologic study of 19 cases.
Barbashina V; Benevenia J; Aviv H; Tsai J; Patterson F; Aisner S; Cohen S; Fernandes H; Skurnick J; Hameed M
J Cancer Res Clin Oncol; 2002 Nov; 128(11):610-6. PubMed ID: 12458341
[TBL] [Abstract][Full Text] [Related]
32. Detection of SYT-SSX rearrangements in synovial sarcomas by real-time one-step RT-PCR.
Nikiforova MN; Groen P; Mutema G; Nikiforov YE; Witte D
Pediatr Dev Pathol; 2005; 8(2):162-7. PubMed ID: 15747098
[TBL] [Abstract][Full Text] [Related]
33. Clear cell sarcoma of soft tissue: a clinicopathologic, immunohistochemical, and molecular analysis of 33 cases.
Hisaoka M; Ishida T; Kuo TT; Matsuyama A; Imamura T; Nishida K; Kuroda H; Inayama Y; Oshiro H; Kobayashi H; Nakajima T; Fukuda T; Ae K; Hashimoto H
Am J Surg Pathol; 2008 Mar; 32(3):452-60. PubMed ID: 18300804
[TBL] [Abstract][Full Text] [Related]
34. Change of E-cadherin by hepatocyte growth factor and effects on the prognosis of hypopharyngeal carcinoma.
Kim CH; Kim J; Kahng H; Choi EC
Ann Surg Oncol; 2007 May; 14(5):1565-74. PubMed ID: 17294073
[TBL] [Abstract][Full Text] [Related]
35. Prognostic significance of dysadherin and E-cadherin expression in patients with head and neck cancer treated by radiation therapy.
Muramatsu H; Akimoto T; Maebayashi K; Kita M; Mitsuhashi N
Anticancer Res; 2008; 28(6B):3859-64. PubMed ID: 19192641
[TBL] [Abstract][Full Text] [Related]
36. The SYT-SSX1 variant of synovial sarcoma is associated with a high rate of tumor cell proliferation and poor clinical outcome.
Nilsson G; Skytting B; Xie Y; Brodin B; Perfekt R; Mandahl N; Lundeberg J; Uhlén M; Larsson O
Cancer Res; 1999 Jul; 59(13):3180-4. PubMed ID: 10397263
[TBL] [Abstract][Full Text] [Related]
37. Synovial sarcoma of the stomach: a clinicopathologic, immunohistochemical, and molecular genetic study of 10 cases.
Makhlouf HR; Ahrens W; Agarwal B; Dow N; Marshalleck JJ; Lee EL; Dotto JE; Hui P; Sobin LH; Oliveira A; Miettinen M
Am J Surg Pathol; 2008 Feb; 32(2):275-81. PubMed ID: 18223331
[TBL] [Abstract][Full Text] [Related]
38. Ossifying synovial sarcoma.
Hisaoka M; Matsuyama A; Shimajiri S; Akiba J; Kusano H; Hiraoka K; Shoda T; Hashimoto H
Pathol Res Pract; 2009; 205(3):195-8. PubMed ID: 19041192
[TBL] [Abstract][Full Text] [Related]
39. Prognostic significance of dysadherin expression in esophageal squamous cell carcinoma.
Shimada Y; Hashimoto Y; Kan T; Kawamura J; Okumura T; Soma T; Kondo K; Teratani N; Watanabe G; Ino Y; Sakamoto M; Hirohashi S; Imamura M
Oncology; 2004; 67(1):73-80. PubMed ID: 15459499
[TBL] [Abstract][Full Text] [Related]
40. Expression of dysadherin and cytokeratin as prognostic indicators of disease-free survival in patients with stage I NSCLC.
Ono K; Uramoto H; Hanagiri T
Anticancer Res; 2010 Sep; 30(9):3273-8. PubMed ID: 20944097
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]